Therapeutic repair of mutated nucleic acid sequences

@article{Woolf1998TherapeuticRO,
  title={Therapeutic repair of mutated nucleic acid sequences},
  author={Tod M. Woolf},
  journal={Nature Biotechnology},
  year={1998},
  volume={16},
  pages={341-344}
}
  • T. Woolf
  • Published 1 April 1998
  • Biology
  • Nature Biotechnology
The principle of therapeutic nucleic acid repair has been demonstrated in cell-free and cell culture experiments, in which compounds bind to and repair mutated sequences, thereby treating the primary defects of genetic disease. The mechanisms used to promote repair are diverse, encompassing techniques related to antisense, triple-strand, and ribozymes. Therapeutic nucleic acid repair has the potential to revert mutations to wild type, and therefore is more suitable than traditional gene therapy… 

Improving site-directed RNA editing in vitro and in cell culture by chemical modification of the guideRNA.

TLDR
Dense chemical modification of the guideRNA clearly improves performance of the covalent conjugates inside the living cell and was exploited for the challenging repair of the Factor 5 Leiden missense mutation.

Site-directed RNA editing: recent advances and open challenges

TLDR
An overview on the current status and technical differences of site-directed RNA-editing approaches is provided and advantages and challenges of individual approaches are discussed.

Suitability of oligonucleotide‐mediated cystic fibrosis gene repair in airway epithelial cells

TLDR
Non‐viral vector‐mediated targeted gene repair could become a useful alternative to classical gene addition strategies, with reported gene conversion and phenotypic correction efficiencies approaching 40–50% in some in vitro and in vivo models of disease.

In vitro correction of cystic fibrosis epithelial cell lines by small fragment homologous replacement (SFHR) technique

TLDR
It is demonstrated that the lipid/DNA (+/-) ratio influences the mode of entry into the cell and therefore affects the efficacy of SFHR-mediated gene targeting, and there is a correlation between the specific cell line transfected and the optimal lipid/ DNA ratio.

Active oligonucleotides incorporating alkylating an agent as potential sequence- and base selective modifier of gene expression.

  • S. Sasaki
  • Biology, Chemistry
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
  • 2001

Stable and inheritable changes in genotype and phenotype of albino melanocytes induced by an RNA-DNA oligonucleotide

TLDR
A permanent and stable gene correction by the RNA-DNA oligonucleotide at the level of genomic sequence, protein, and phenotypic change by clonal analysis is demonstrated.

Non‐viral vector‐mediated uptake, distribution, and stability of chimeraplasts in human airway epithelial cells

TLDR
Chimeraplasty is a novel methodology that uses chimeric RNA/DNA oligonucleotides (chimeraPLasts) to stimulate genomic DNA repair to achieve optimal correction of mutation defects into specific cell types.

Quantitative Assessment of Chimeraplast Stability in Biological Fluids by Polyacrylamide Gel Electrophoresis and Laser-Assisted Fluorescence Analysis

TLDR
In this study, an antisense oligonucleotide has been approved for the treat-ment of human cytomegalovirus-induced retinitis and severaloligonucleotide-mediated gene targeting approaches have been envisioned with the purpose of blocking sequence-specific transcription.

Virus-Like Particle Mediated CRISPR/Cas9 Delivery for Efficient and Safe Genome Editing

TLDR
This review will talk through commonly used genome editing nucleases, discuss gene editing delivery tools and review the latest literature using virus-like particles to deliver gene editing effectors.

References

SHOWING 1-10 OF 18 REFERENCES

Toward the therapeutic editing of mutated RNA sequences.

TLDR
A synthetic complementary RNA oligonucleotide was hybridized to a premature stop codon and the hybrid was treated with nuclear extracts containing the cellular enzyme double-stranded RNA adenosine deaminase, causing a dramatic increase in expression of a downstream luciferase coding region.

Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA.DNA oligonucleotide.

TLDR
The results extend the usefulness of the oligonucleotide-based gene targeting approaches by increasing specific targeting frequency and should enable the design of antiviral agents.

Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA-DNA Oligonucleotide

TLDR
A chimeric oligonucleotide composed of DNA and modified RNA residues was used to direct correction of the mutation in the hemoglobin βS allele and there was a detectable level of gene conversion of the mutant allele to the normal sequence.

Targeted mutagenesis in mammalian cells mediated by intracellular triple helix formation

TLDR
The ability to target mutations to selected sites within mammalian cells by using modified triplex-forming oligonucleotides may provide a new research tool and may eventually lead to therapeutic applications.

Targeted nucleotide exchange in the alkaline phosphatase gene of HuH‐7 cells mediated by a chimeric RNA/DNA oligonucleotide

TLDR
Results show that a single base pair alteration in the alkaline phosphatase gene of HuH‐7 cells can be introduced at a relatively high frequency following transfection with chimeric RNA/DNA oligonucleotides.

Tagging ribozyme reaction sites to follow trans–splicing in mammalian cells

TLDR
It is demonstrated that a trans–splicing group I ribozyme can be employed to intentionally modify the sequence of targeted transcripts in tissue culture cells, providing direct evidence that ribozymes function as anticipated in a therapeutically relevant setting.

Gene therapy - promises, problems and prospects

TLDR
The prospects are good — by the year 2010, gene therapy may be as routine a practice as heart transplants are today.

Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides.

TLDR
Treatment of mammalian cells stably expressing the IVS2-654 human beta-globin gene with antisense oligonucleotides targeted at the aberrant splice sites restored correct splicing in a dose-dependent fashion, generating correct human Beta- globin mRNA and polypeptide.

Injected anti-sense RNAs specifically block messenger RNA translation in vivo.

  • D. Melton
  • Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 1985
TLDR
This method may allow one to study the function of many genes for which DNA clones are available by preventing the expression of the endogenous gene as protein by microinjection of complementary (anti-sense) RNA.